{"name":"Medigene AG","slug":"medigene-ag","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"G207, an oncolytic virus","genericName":"G207, an oncolytic virus","slug":"g207-an-oncolytic-virus","indication":"Other","status":"phase_1"},{"name":"Veregen","genericName":"Veregen","slug":"veregen","indication":"Other","status":"marketed"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"EndoTAG-1 and Gemcitabine","genericName":"EndoTAG-1 and Gemcitabine","slug":"endotag-1-and-gemcitabine","indication":"Pancreatic cancer","status":"phase_2"}]}],"pipeline":[{"name":"G207, an oncolytic virus","genericName":"G207, an oncolytic virus","slug":"g207-an-oncolytic-virus","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"EndoTAG-1 and Gemcitabine","genericName":"EndoTAG-1 and Gemcitabine","slug":"endotag-1-and-gemcitabine","phase":"phase_2","mechanism":"EndoTAG-1 is a peptide that targets the tumor vasculature, while Gemcitabine is a nucleoside analog that interferes with DNA synthesis.","indications":["Pancreatic cancer"],"catalyst":""},{"name":"Veregen","genericName":"Veregen","slug":"veregen","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxNeFdDbU8wVzhVcXhjRHh2X1lXVDhQLUdPcmdrQVRybW9WZzhha1hWTjEza2QxSDh1cDRacjVva0d5a2dvZjJRLWpMSl91TGNTRXUyWFBNWXplb2ZLYzdadzlCQmhUOWlvblRCSlFpcXQyeEw5bUNaOVRmUkRXRFBsZGsxbzY0WWJtWFUySw?oc=5","date":"2026-03-31","type":"pipeline","source":"Contract Pharma","summary":"Signadori Bio Taps Dr. Selwyn Ho as CEO - Contract Pharma","headline":"Signadori Bio Taps Dr. Selwyn Ho as CEO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTFBxUHVIZGNBRWQ0TFdOYnBuVHkwb2wtRlFFX28xSC1OcERjSzJiV2pIY29VQVQ3bDc4UnlmRnNhQjNmVW9FSV91d0ZYRW40TS0xajJhSzBtLVRKcDNCYUtidmFKWXBMZEdsaVFjd0xtaHJWaFVmMjRYOHNtQUl2azQ?oc=5","date":"2025-04-03","type":"pipeline","source":"PharmTech.com","summary":"Engineered T Cell Receptor-T Cell Therapies - PharmTech.com","headline":"Engineered T Cell Receptor-T Cell Therapies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgJBVV95cUxPRTBWdVRBLXdKa2F3SXBFNUFiZXc0amRxaDlVZ1dwRmM5Vm52bGk3XzlJRGw1elVKelFWRXFjUVJFTUNPZVBvRU1pM3M3SEdnMHYxQ21iT2ppcWJNcG5UTlhYVGFQTmpKQzNWdmJOZ1ZxN2V6a01Eek81RkV6cmlMWEFfLVU5S05IaFBGWFc5Y3F2UUl2Uk1fcldkQzRGT0pfZUZ0UklXMDZrallYUnNmdy1hZGVXSHpBczJSSmVYaXR0dGJPZWNfQXJaU2pydkxoMmRTcHNSZG5pVEp2dFlZRHBPOU9jdTNFS3NfSzdHb0dBWmZDZ0xVZDNpd2NqRUJteThYaDVKVGJ1NWVXVE1LZ1hBWVNyQmR2aENJb0FYb283WGRWb0EwS3A0Zlo2cDVwWlc0c2JR?oc=5","date":"2025-01-08","type":"pipeline","source":"PR Newswire","summary":"Botanical and Plant-Derived Drugs Market to Grow by USD 18.66 Billion (2025-2029), Driven by Government Initiatives and AI Impact on Market Trends - Technavio - PR Newswire","headline":"Botanical and Plant-Derived Drugs Market to Grow by USD 18.66 Billion (2025-2029), Driven by Government Initiatives and ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxOem95YmlIaU9iOXpaYXctQ0wzQWNjcGpJWjRVRHAtam1wQ2dyNmYwZEFRVG10djJkMHJ4UUFoQXI3VjVtcjJKVDlmZDZkRnNmRm9EQWJ0S3BIcnRNWjRnbDNkUHZaU0swYkgyYmRXTnVyaWwteGpoYWRZamUtSFBxVmZKU29iUTg?oc=5","date":"2024-11-26","type":"pipeline","source":"pharmaphorum","summary":"Medigene axes staff and refocuses its TCR pipeline - pharmaphorum","headline":"Medigene axes staff and refocuses its TCR pipeline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxOaWdXWDlfN1dJLXRVWGhtOTBrWVoyNmg3VWs1T2VpS1hKcUJiUHBNTUx4Mkh2aW5EbFRwbGZxN0NULVhMbks2NzR3V3VZSGtNa21oN0ZYTm5ybTFhRkpNRXdYMWNzN201T0JHT1RmV1BvcEdieE9YY1doc28tTUM2WElOYVMwSGlxbTlXdjNfQ3d2aUk5cDBEYV9ZdmpQWW9y?oc=5","date":"2024-11-26","type":"pipeline","source":"Fierce Biotech","summary":"Cash-strapped Medigene lays off 40% of staff, pauses plan to enter clinic - Fierce Biotech","headline":"Cash-strapped Medigene lays off 40% of staff, pauses plan to enter clinic","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2gFBVV95cUxQOXlwYUpZdFBpUmlISlpwUW1hUWZiOU8ydkRNLTctTHFSLXVod25xUWhHYzFOdnBMTGg2ejAxbHNYRlVxaVk0YU9abkYwd2RJSXFTRVNBQlJWVE9NOG44NVQyT19yRnVpZGJZUXp3SmxBaFRid2FncUhIOGhmVVBucFJoRmRNSUYtZm03MGFTeUhLcGN2aWxCZ2x1WnZNbmhrMjRSM0wtT1JndG96NnRjUGxMRVF2dFpVblhNcUFIN0NCb09BTC1VQ2V4WGlhcGs2Vl8tVnppdTMtUQ?oc=5","date":"2024-08-14","type":"earnings","source":"Investing.com UK","summary":"Earnings call: Medigene AG reports a 45% revenue increase in the first half of 2024 - Investing.com UK","headline":"Earnings call: Medigene AG reports a 45% revenue increase in the first half of 2024","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiTkFVX3lxTE1SY05wS3pTYWVSU1l1SzJXZ2l2VWNWcUdPMGxIY2RCWnRfdEhPWFNmOW1BSmt0b3kxTC1xUk81M09hWi1QRFptQU9pRnJpUQ?oc=5","date":"2024-08-03","type":"pipeline","source":"eToro","summary":"Medigene AG (MDG1.DE) Stock Price, News & Analyst Forecast - eToro","headline":"Medigene AG (MDG1.DE) Stock Price, News & Analyst Forecast","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxQbW02MnppanNXZkdoS25RRVpYT2tjbjhEQU5qWlVDb21wdzhEMkZUeUFkRlB5bmE2dVlKcnEzWjJzTTRRNVUyZkJEMElRLURyRkg2dzlGMmYzQTdpSUFrcjIzbkVHX0FuNVRfZ1E1TDhyOXVlRDZITENHZFpIVlVGcWxtWXJGLS11OHBPemtxYkJWVzh2NkVsaVBJejBoRXh5UXpNMGhjMmk2LWZTaElvbGh6NW9HS2RlQnl0cw?oc=5","date":"2018-01-26","type":"regulatory","source":"Caixin Global","summary":"U.S. Approval Offers Shot in the Arm to China’s Traditional Medicine - Caixin Global","headline":"U.S. Approval Offers Shot in the Arm to China’s Traditional Medicine","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxQQmxxZU9yNjhfTk5IWXlyU0tPUmdtSW1kTS0wbERjeDZPdHBtUlJFeHhxRVVOMTRUVEg0eXYwRVhfRENUWVhwSlBjVVdnT0dXR1dkUWJFZkFwU28tcFNGS19WRkJISkFCM3lKWEtpbENoZXFQSFQ5OXF5Umo3c3ZEb1lYMlE0V0VRbzhQdXJ4Q1ZLb3J0YUM4Wlo5TENzSEozekJRYkJNS1BXdHZaTlE?oc=5","date":"2014-01-09","type":"pipeline","source":"The Pharma Letter","summary":"Priaxon AG appoints Constance Hoefer as chief development officer - The Pharma Letter","headline":"Priaxon AG appoints Constance Hoefer as chief development officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxOME52RU5XSDNHQURERlAtekVNX3hoSVJQSDRYOWJfV1dFQVJoRHVvVVlWUWx3dUVwcGo0VEhZamNncVhqME1POWRZRFdUb0ItU0VUVlZGNXZCMTg1TDZ3c0VLUTF3RlhIV1pxT1BnTmZ0VGw4bXh5T2ljdXVwU1Bxczgtd08?oc=5","date":"2011-10-31","type":"pipeline","source":"Pharmafile","summary":"Working Life: Adaptimmune’s Helen Tayton-Martin - Pharmafile","headline":"Working Life: Adaptimmune’s Helen Tayton-Martin","sentiment":"neutral"}],"patents":[],"drugCount":3,"phaseCounts":{"phase_1":1,"phase_2":1,"marketed":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}